SecBot SecBot
3 ·Filed Oct 19, 2026

CGON

CG Oncology, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed9d 4h ago SEC0001193125-26-425256
Form 3, initial insider ownership statement
Actionable Insight • Neutral

Monitor future Form 4 filings for any open-market purchases or sales by the new Chief Commercial Officer, which could signal insider conviction or sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+5d
CGON ▲ +1.63% at T+5d
NEUTRAL call +1.63% · α vs SPY +1.55% · entry $61.93 → $62.94
Next anchor: T+20d in 18d
Entry = T+0 close
Oct 19, 2026
via day close
T+1d
+0.50%
call +0.50% · α -0.02%
$62.24
settled 9d ago
T+5d
+1.63%
call +1.63% · α +1.55%
$62.94
settled 3d ago
T+20d
Pending
in 18d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Isabel Kalofonos filed a Form 3 initial statement of beneficial ownership with CG Oncology, Inc., reporting her position as Chief Commercial Officer. The filing is a routine Section 16 requirement for new officers and contains no trading activity or material financial information.

Key Facts

  • Isabel Kalofonos filed a Form 3 initial statement of beneficial ownership on 2026-10-19, reporting a date of 2026-10-13.
  • Kalofonos is listed as Chief Commercial Officer of CG Oncology, Inc.
  • The filing includes a power of attorney authorizing attorneys to execute future Section 16 filings.
  • No securities holdings or transaction amounts are disclosed in the filing.

Financial Impact

No financial impact, the filing is a routine initial ownership statement with no disclosed holdings or transactions.

Risk Factors

  • No material risks identified from this routine filing.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-425256
Document: 0001193125-26-425256-index-headers.html0001193125-26-425256
Document: 0001193125-26-425256-index.html0001193125-26-425256
Document: 0001193125-26-425256.txt0001193125-26-425256
20 reports for CGON
Performance horizon
86% Hit rate @ T+20 6 of 7 directional calls Went positive at some point 7 of 7 best @ T+20▲ +26.33%Jun 12, 2026
Filters
Rows
Reports for CGON, sortable and filterable
TypeNow
Oct 19, 2026
9d ago
3
NEUTRAL ★ 2/10
$61.93awaiting T+20awaiting T+20$62.94 (+1.63%)
Oct 15, 2026
13d ago
144
NEUTRAL ★ 2/10
$59.85awaiting T+20awaiting T+20$62.94 (+5.16%)
Oct 12, 2026
16d ago
Institutional Cluster
MIXED ★ 3/10
$63.13awaiting T+20awaiting T+20$62.94 (−0.30%)
Aug 6, 2026
11w ago
Press Release
BEARISH ★ 7/10
$74.85 $74.33▲ +0.69%▲ +1.29%$62.94 (+15.91%)
Aug 6, 2026
11w ago
424B5
BEARISH ★ 6/10
$74.85 $74.33▲ +0.69%▲ +1.29%$62.94 (+15.91%)
Jul 27, 2026
13w ago
Press Release
BULLISH ★ 7/10
$72.62 $78.95▲ +8.72%▲ +5.34%$62.94 (−13.33%)
Jul 17, 2026
14w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.19 $77.11▲ +9.86%▲ +5.74%$62.94 (−10.33%)
Jul 16, 2026
15w ago
Court Ruling
BULLISH ★ 7/10
$71.85 $75.03▲ +4.43%▼ −0.02%$62.94 (−12.40%)
Jun 24, 2026
18w ago
144
NEUTRAL ★ 2/10
$72.84 $71.12▼ −2.36%▼ −2.89%$62.94 (−13.59%)
Jun 22, 2026
18w ago
144
NEUTRAL ★ 3/10
$65.73 $70.19▲ +6.79%▲ +5.63%$62.94 (−4.24%)
Showing 10 of 20

US Market Status

Market Closed · Opens Fri (12h 44m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 19, 2026